Crystal Structure of 2-(1-benzyl-3-phenyl-1h-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S

Xu-Wen Huang,Jin-Zong You,Wan-Min Ni,Yi-Ping Zhang,Qi Feng,Wen-Chang Xu,Sheng-Yue Tong,Tang-Qi Li,De-Qiang Qi
DOI: https://doi.org/10.1515/ncrs-2016-0262
2017-01-01
Zeitschrift für Kristallographie - New Crystal Structures
Abstract:C25H19N5O3S, monoclinic, P21/c (no. 14), a = 16.715(2) Å, b = 11.2677(15) Å, c = 12.6490(17) Å, β = 110.818(2)°, V = 2226.7(5) Å3, Z = 4, Rgt(F) = 0.0424, wRref(F2) = 0.1037, T = 296 K.
What problem does this paper attempt to address?